| Literature DB >> 31718107 |
Chung-Hsuan Ku1, Wen-Hung Huang1, Ching-Wei Hsu1, Yu-Chin Chen2,3, Yi-Chou Hou4, I-Kuan Wang5, Hsiang-Hsi Hong6, Yen-Li Wang7, Cheng-Hao Weng1, Tzung-Hai Yen1.
Abstract
Objective: This study examined predictors of globus pallidus necrosis as there was a paucity of literature of globus pallidus necrosis resulted from carbon monoxide poisoning after charcoal burning suicide.Entities:
Keywords: charcoal burning; globus pallidus necrosis; mortality; suicide
Mesh:
Substances:
Year: 2019 PMID: 31718107 PMCID: PMC6888208 DOI: 10.3390/ijerph16224426
Source DB: PubMed Journal: Int J Environ Res Public Health ISSN: 1660-4601 Impact factor: 3.390
Clinical data of patients who had attempted charcoal burning suicide, stratified by either presence or absence of globus pallidus necrosis (n = 67).
| Variables | All Patients ( | Patients with Globus Pallidus Necrosis ( | Patients without Globus Pallidus Necrosis ( | |
|---|---|---|---|---|
| Demographics | ||||
| Age, year | 36.8 ± 11.1 | 34.5 ± 9.6 | 40.1 ± 12.4 | 0.044 * |
| Male, | 45 (67.2) | 25 (62.5) | 20 (74.1) | 0.428 |
| Hypertension, | 7 (10.4) | 1 (2.5) | 6 (22.2) | 0.015 * |
| Diabetes mellitus, | 6 (9.0) | 2 (5.0) | 4 (14.8) | 0.211 |
| Hepatitis B or C virus carrier, | 6 (9.0) | 3 (7.5) | 3 (11.1) | 0.679 |
| Liver cirrhosis | 1 (1.5) | 0 (0) | 1 (3.7) | 0.403 |
| Smoking habit, | 37 (55.2) | 21 (52.5) | 16 (59.3) | 0.796 |
| Chronic alcohol consumption, | 33 (49.3) | 19 (47.5) | 14 (51.9) | 0.885 |
| Past suicide history, | 13 (19.4) | 7 (17.5) | 6 (22.2) | 0.647 |
| Mood disorder, | 38 (56.7) | 23 (57.5) | 15 (55.6) | 0.670 |
| Adjustment disorder, | 25 (37.3) | 14 (35.0) | 11 (40.7) | 0.797 |
| Clinical manifestations | ||||
| Systolic blood pressure, mmHg | 115.6 ± 32.4 | 113.0 ± 31.8 | 119.4 ± 23.7 | 0.403 |
| Heart rate, per minute | 97.6 ± 23.4 | 101.9 ± 21.0 | 91.2 ± 21.3 | 0.066 |
| Fever, | 23 (34.3) | 19 (47.5) | 4 (14.8) | 0.008 ** |
| Acute respiratory failure, | 27 (40.3) | 20 (50.0) | 7 (25.9) | 0.075 |
| Acute myocardial infarction, | 27 (40.3) | 21 (52.5) | 6 (22.2) | 0.022 * |
| Acute hepatic injury, | 29 (43.3) | 21 (52.5) | 8 (29.6) | 0.081 |
| Acute kidney injury, | 29 (43.3) | 20 (50.0) | 9 (33.3) | 0.214 |
| Acute rhabdomyolysis, | 27 (40.3) | 21 (52.5) | 6 (22.2) | 0.022 * |
| Neuropsychiatric symptoms, | 34 (50.7) | 28 (70.0) | 6 (22.2) | <0.001 *** |
| Stroke, | 8 (11.9) | 7 (17.5) | 1 (3.7) | 0.103 |
| Shock, | 7 (10.4) | 5 (12.5) | 2 (7.4) | 0.693 |
| Out-of-hospital cardiac arrest, | 2 (3.0) | 2 (22.2) | 0 (0) | 0.512 |
| Laboratory findings (normal range) | ||||
| Carboxyhemoglobin, % (nonsmoker 0.5–1.5, smoker 4–9) | 21.8 ± 19.3 | 18.4 ± 3.2 | 26.7 ± 3.5 | 0.086 |
| Blood urea nitrogen, mg/dL (6–21) | 18 (10.0, 20.9) | 19.9 (10.6, 23.3) | 15 (9.0, 20.9) | 0.164 |
| Creatinine, mg/dL (M 0.64–1.27, F 0.44–1.03) | 1.20 (0.8, 1.6) | 1.4 (0.9, 2.1) | 0.9 (0.8, 1.5) | 0.022 * |
| Calcium, mg/dL (7.9–9.9) | 8.1 ± 0.5 | 8.0 ± 0.6 | 8.2 ± 0.4 | 0.111 |
| Phosphate, mg/dL (2.4–4.7) | 3.3 ± 0.7 | 3.4 ± 0.8 | 3.3 ± 0.5 | 0.722 |
| Sodium, mEq/L (134–148) | 141.6 ± 3.1 | 141.8 ± 3.3 | 141.4 ± 2.9 | 0.613 |
| Potassium, mEq/L (3.6–5.0) | 4.2 ± 0.8 | 4.3 ± 0.8 | 4.1 ± 0.7 | 0.279 |
| Albumin, g/dL (3.5–5.5) | 3.4 ± 0.6 | 3.4 ± 0.4 | 3.4 ± 0.8 | 0.988 |
| Aspartate transaminase, U/L (≤34) | 75.0 (30.0, 196.1) | 119.0 (55.3, 206.8) | 39.0 (21.0, 150.0) | 0.001 ** |
| Alanine transaminase, U/L (≤36) | 58.0 (26.5, 102.0) | 77.0 (41.0, 104.0) | 42.0 (17.3, 98.3) | 0.080 |
| Alkaline phosphatase, U/L (36–122) | 60.2 ± 30.6 | 48.5 ± 3.7 | 76.3 ± 14.5 | 0.101 |
| Bilirubin total mg/dL (≤1.3) | 0.7 ± 0.3 | 0.8 ± 0.2 | 0.6 ± 0.4 | 0.479 |
| Troponin I, ng/mL (<0.4) | 0.9 (0.2, 2.8) | 1.7 (0.6, 5.9) | 0.1 (0.0, 0.8) | <0.001 *** |
| Creatine kinase, U/L | 2029.0 (238.0, 7227.0) | 4610.0 (504.5, 13704.0) | 303.0 (100.3, 2164.0) | 0.020 * |
| Creatine kinase-MB, U/L (0.6–6.3) | 11.9 (3.7, 28.5) | 19.2 (8.8, 30.5) | 4.1 (0.8, 12.5) | 0.014 * |
| Myoglobin, ng/mL | 370.7 (180.6, 386.7) | 386.7 (96.7, 1023.2) | 41.8 (19.9, 166.1) | 0.061 |
| Hemoglobin, g/dL | 14.7 ± 2.2 | 14.6 ± 2.4 | 14.8 ± 2.0 | 0.800 |
| White blood cell count, 103/uL | 15.982 ± 8.064 | 16.592 ± 1.241 | 15.077 ± 1.624 | 0.455 |
| Polymorphonuclear neutrophil, % (42–77) | 81.6 ± 13.1 | 82.7 ± 13.7 | 80.0 ± 12.2 | 0.417 |
| Platelet cell count, 103/uL (150–400) | 227.9 ± 71.2 | 228.7 ± 68.9 | 226.8 ± 75.7 | 0.917 |
| C-reactive Protein, mg/L (<5) | 29.2 (15.1, 74.2) | 29.2 (13.8, 80.3) | 27.6 (14.8 81.8) | 0.897 |
| Arterial blood gas | ||||
| pH (M 7.34–7.44, F 7.35–7.45) | 7.37 ± 0.11 | 7.35 ± 0.13 | 7.40 ± 0.07 | 0.061 |
| Partial pressure of carbon dioxide, mmHg (M 35–45, F 32–42) | 35.1 ± 6.7 | 34.5 ± 6.4 | 36.0 ± 7.1 | 0.375 |
| Partial pressure of oxygen, mmHg (75–100) | 241.1 ± 146.4 | 235.7 ± 25.4 | 249.0 ± 24.0 | 0.706 |
| Bicarbonate, mmol/L | 20.3 ± 4.5 | 19.1 ± 4.5 | 22.1 ± 4.1 | 0.007 ** |
| Treatment and outcomes | ||||
| Oxygen therapy using non-rebreather facemask, | 67 (100.0) | 40 (100.0) | 27 (100.0) | 1.000 |
| Hyperbaric oxygen therapy, | 28 (41.8) | 12 (30.0) | 16 (59.3) | 0.024 * |
| Mortality, | 2 (3.0) | 2 (22.2) | 0 | 0.512 |
Note: F, female; M, male. * p < 0.05, ** p < 0.01, *** p < 0.001. Continuous variables are expressed as means ± standard deviations whereas categorical variables are expressed as numbers (percentages). Non-normal distribution data were presented as median (interquartile range).
Univariable logistic regression analysis of predictors for globus pallidus necrosis (n = 67).
| Variable | Odds Ratio (95% Confidence Interval) | |
|---|---|---|
| Acute myocardial injury (yes) | 3.9 (1.3–11.6) | 0.016 * |
| Neuropsychiatric symptoms (yes) | 8.2 (2.6–25.3) | <0.001 *** |
| Bicarbonate level (each increment of 1 mmol/L) | 0.8 (0.7–1.0) | 0.010 * |
| Age (each increase of 1 year) | 1.0 (0.9–1.0) | 0.050 * |
| Acute rhabdomyolysis (yes) | 3.9 (1.3–11.6) | 0.016 * |
| Hyperbaric oxygen therapy (yes) | 0.3 (0.1–0.8) | 0.019 * |
| Creatinine level (each increment of 1 mg/dL) | 2.8 (1.0–7.6) | 0.044 * |
| Fever (yes) | 5.2 (1.5–17.8) | 0.009 ** |
| Hypertension (yes) | 0.1 (0.0–0.8) | 0.030 * |
| Aspartate transaminase (each increment of 1 U/L) | 1.0 (1.0–1.0) | 0.021 * |
Note: * p < 0.05, ** p < 0.01, *** p < 0.001.
Multivariable logistic regression analysis of predictors for globus pallidus necrosis (n = 67).
| Variable | Odds Ratio (95% Confidence Interval) | |
|---|---|---|
| Acute myocardial injury (yes) | 4.6 (1.1–18.9) | 0.034 * |
| Neuropsychiatric symptoms (yes) | 8.0 (2.0–31.4) | 0.003 ** |
| Bicarbonate level (each increment of 1 mmol/L) | 0.8 (0.7–1.0) | 0.032 * |
| Age (each increment of 1 year) | 0.9 (0.9–1.0) | 0.038 * |
Note: * p < 0.05, ** p < 0.01, *** p < 0.001.
Comparison of outcomes between current and published studies (sample size ≥5) from different geographic areas.
| Study | Year | Country | Source of Carbon Monoxide | Sample Size | Incidence Rate of Globus Pallidus Necrosis, % | Mortality Rate, % |
|---|---|---|---|---|---|---|
| Current study | 2019 | Taiwan | Charcoal burning | 67 | 59.7 | 3.0% |
| Jeon et al. [ | 2018 | Korea | Not mentioned | 387 | 19.9 | Not mentioned |
| Moon et al. [ | 2018 | Korea | Charcoal burning | 128 | 18.7 | 0% |
| Kim et al. [ | 2017 | Korea | Not mentioned | 7 | 100.0 | Not mentioned |
| Chen et al. [ | 2013 | Taiwan | Charcoal burning | 47 | 25.5 | Not mentioned |
| Chen et al. [ | 2013 | Taiwan | Not mentioned | 30 | 53.0 | Not mentioned |
| Chen et al. [ | 2005 | China | Not mentioned | 46 | 82.1 (magnetic resonance imaging); 43.2 (computed tomography) | Not mentioned |
| Durak et al. [ | 2005 | Turkey | Not mentioned | 8 | 37.5 | Not mentioned |
| Kim et al. [ | 2003 | Korea | Not mentioned | 5 | 100.0 | Not mentioned |
| O’Donnell et al. [ | 1999 | UK | Not mentioned | 19 | 63.2 | 21.1% |
| Matsushita et al. [ | 1996 | Japan | Not mentioned | 13 | 38.4 | Not mentioned |
| Jones et al. [ | 1994 | USA | Not mentioned | 19 | 36.8 | 1.0% |
| Chang et al. [ | 1992 | Korea | Not mentioned | 15 | 60.0 | Not mentioned |